Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 5Phase NA 3Phase 2/3 3Phase 1/2 3Phase 1 3Phase 4 1

Status

Completed 19Recruiting 16Unknown 14Not yet recruiting 5Active not recruiting 5Terminated 3Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 41Carcinoma, Non-Small-Cell Lung 27Colorectal Neoplasms 17Neoplasms 13Prostatic Neoplasms 11Nasopharyngeal Carcinoma 11Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 10Leukemia, Myeloid, Acute 9Stomach Neoplasms 8Small Cell Lung Carcinoma 8Ovarian Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Rectal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Recurrence 5Glioblastoma 5Esophageal Squamous Cell Carcinoma 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Brain Neoplasms 5Adenocarcinoma 5Urinary Bladder Neoplasms 4Lymphoma, Follicular 4

Interventions

toripalimab 2Irinotecan 2Drug Therapy 2sintilimab 1irinotecan sucrosofate 1Radiotherapy 1Paclitaxel 1Leucovorin 1Injections 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Esophageal Squamous Cell Carcinoma × Clear all
NCT07621601 2026-06-02

A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Hansoh BioMedical R&D Company

Phase 3 Not yet recruiting
494 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis

NCT06952621 2026-01-30

TD-NEOE3V3

Tang-Du Hospital

Phase 3 Not yet recruiting
390 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07246330 2025-11-24

Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Not yet recruiting
340 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06501664 2024-07-15

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Sun Yat-sen University

Phase 3 Not yet recruiting
360 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05244798 2022-10-25

Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

Sichuan Cancer Hospital and Research Institute

Phase 3 Not yet recruiting
420 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡